Blue Light Phototherapy

Completed · Not applicable

Conditions studied: Grover's Disease, Psoriasis Vulgaris

In brief

This study will use Blue-light Photo-therapy to treat patients with psoriasis vulgaris and Grover's Disease.

Key facts

Study ID

NCT04343586

Run by

Northwestern University

People needed

11

Starts

2020-09-01

Expected to finish

2022-09-22

Last updated by the study team

2023-03-17

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient's aged 18-89 at time of enrollment
• Previous diagnosis of psoriasis vulgaris or Grover's disease

You may not qualify if…

• All Groups: Subjects who are younger than 18 years of age or older than 90 years of age
• Patients who have received topical or systemic treatment within the prior 2 weeks of planned phototherapy
• Patients prescribed any of the following drugs for issues not related to their psoriasis or Grover's disease
• topical steroids
• calcineurin inhibitors
• methotrexate
• retinoids
• biologic agents
• Unable to schedule phototherapy sessions
• We will not recruit the following populations: adults unable to consent, individuals who are not yet adults (infants, children, teenagers), pregnant women, prisoners and other vulnerable populations.

Where it is running

• Northwestern University Department of Dermatology — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.